on 8 Jun 2022
Last Applicant/ Owned by
Mirum Pharmaceuticals, Inc.
989 E Hillsdale Blvd., Suite 300Foster City CA 94404
US
Serial Number
2059232 filed on 8th Sept 2020
Registration Number
TMA1131257 registered on 8th Jun 2022
Registration expiry Date
8th Sept 2030Correspondent Address
GOWLING WLG (CANADA) LLP
SUITE 2600, 160 ELGIN STREETOTTAWA
ONTARIO
CA
K1P1C3
Trademark usage description
pharmaceutical preparations for the treatment of liver disease.11
2059232
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 26 on 18th Feb 2022 | Approved |
Submitted for opposition 27 on 18th Feb 2022 | Approval Notice Sent |
Submitted for opposition 22 on 14th Feb 2022 | Search Recorded |
Submitted for opposition 256 on 23rd Aug 2021 | Notification of Possible Opposition Sent |
Submitted for opposition 48 on 26th Nov 2020 | Agent Changed |
Submitted for opposition 257 on 22nd Oct 2020 | Designation Notification - Madrid Protocol |
Submitted for opposition 1 on 21st Oct 2020 | Created |
Submitted for opposition 31 on 21st Oct 2020 | Formalized |
Submitted for opposition 228 on 8th Sept 2020 | International Registration |
Submitted for opposition 30 on 8th Sept 2020 | Filed |